1. Bangladesh in the era of malaria elimination.
- Author
-
Haldar K, Alam MS, Koepfli C, Lobo NF, Phru CS, Islam MN, Faiz A, Khan WA, and Haque R
- Subjects
- Humans, Plasmodium falciparum, Bangladesh epidemiology, Drug Resistance, Malaria drug therapy, Malaria prevention & control, Malaria parasitology, Malaria, Falciparum drug therapy, Malaria, Falciparum prevention & control, Malaria, Falciparum parasitology, Antimalarials pharmacology, Antimalarials therapeutic use
- Abstract
Bangladesh has dramatically reduced malaria by 93% from 2008 to 2020. The strategy has been district-wise, phased elimination; however, the last districts targeted for elimination include remote, forested regions which present several challenges for prevention, detection, and treatment of malaria. These districts border Myanmar which harbors Plasmodium falciparum malaria parasites resistant to artemisinins, key drugs used in artemisinin-based combination therapies (ACTs) that have been vital for control programs. Challenges in monitoring emergence of artemisinin resistance (AR), tracking parasite reservoirs, changes in vector behavior and responses to insecticides, as well as other environmental and host factors (including the migration of Forcibly Displaced Myanmar Nationals; FDMNs) may pose added hazards in the final phase of eliminating malaria in Bangladesh., Competing Interests: Declaration of interests The authors declare that they have no conflicts of interest., (Copyright © 2023. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF